Market Value341,986,000
Total Holdings60
File Date2021-11-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AVIR / Atea Pharmaceuticals, Inc.
IWM / iShares Trust - iShares Russell 2000 ETF Call
EPIX / ESSA Pharma Inc.
FATE / Fate Therapeutics, Inc.
KURA / Kura Oncology, Inc.
859319303 / Sterling Financial Corp
BLU / Bellus Health Inc
OTIC / Otonomy Inc
PRVB / Provention Bio Inc
PRVB / Provention Bio Inc Put
CRIS / Curis, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
BYSI / BeyondSpring Inc. Call
IMUX / Immunic, Inc.
GHRS / GH Research PLC
TCRR / Tcr2 Therapeutics Inc
VTGN / Vistagen Therapeutics, Inc.
ALLO / Allogene Therapeutics, Inc.
FULC / Fulcrum Therapeutics, Inc.
KDMN / Kadmon Holdings Inc
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
PRAX / Praxis Precision Medicines, Inc.
DNAY / Codex DNA Inc
HRMY / Harmony Biosciences Holdings, Inc.
TRIL / Trillium Therapeutics Inc
CERE / Cerevel Therapeutics Holdings, Inc.
BIIB / Biogen Inc.
LPTX / Leap Therapeutics, Inc.
ALEC / Alector, Inc.
ALDX / Aldeyra Therapeutics, Inc.
CMRX / Chimerix, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
TGTX / TG Therapeutics, Inc.
CASI / CASI Pharmaceuticals, Inc.
ISEE / IVERIC bio Inc
SRRA / Sierra Oncology Inc
ZNTL / Zentalis Pharmaceuticals, Inc.
CBIO / Crescent Biopharma, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
TARS / Tarsus Pharmaceuticals, Inc.
IOVA / Iovance Biotherapeutics, Inc.
NMTR / 9 Meters Biopharma Inc
MRNA / Moderna, Inc.
MRUS / Merus N.V.
CLDX / Celldex Therapeutics, Inc.
ALLK / Allakos Inc.
RLMD / Relmada Therapeutics, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
MLTX / MoonLake Immunotherapeutics
ELEV / Elevation Oncology, Inc.
CABA / Cabaletta Bio, Inc.
COGT / Cogent Biosciences, Inc.
VRDN / Viridian Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
MRSN / Mersana Therapeutics, Inc.
CTIC / CTI BioPharma Corp
XENE / Xenon Pharmaceuticals Inc.
ACRS / Aclaris Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc. Put
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
FOLD / Amicus Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
LRMR / Larimar Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc. Call
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
IMVT / Immunovant, Inc. Call
CRNX / Crinetics Pharmaceuticals, Inc.
ARVN / Arvinas, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.
RAPT / RAPT Therapeutics, Inc.